One thing is clear. Shareholders are about to find out what specifically Allyn meant when he said on October 11, 2013: The Company had a terrific third quarter. When the financial results are released, investors will see that we have continued our long-term focus to collect receivables, enhance revenues, and increase cash on hand -- while investing intelligently in the business. We have also continued to focus on personnel and acquiring the right business relationships, as we expand the Company's role in the medical marijuana space.